Key facts
- Unitree Robotics shares have fallen 55% from their peak.
- Chinese regulators are slowing down IPOs for humanoid robot companies.
- Regulators are scrutinizing revenue streams tied to state-backed projects.
- Investor sentiment is shifting towards greater rationality regarding robotics valuations.
- Unitree Robotics reported 2025 revenue of 1.70 billion yuan.
Shares of Chinese robotics firm Unitree Robotics have fallen 55% from their peak following a strong debut on the Shanghai Stock Exchange's STAR Market, as regulators signal a slowdown in approvals for humanoid robot companies. The stock, which soared more than fivefold in its debut a month ago, has slumped amid concerns that soaring valuations in the sector are not supported by genuine commercial demand.
Chinese regulators are reportedly using informal guidance to hold back some humanoid robot listings, scrutinizing whether high valuations and revenue tied to state-backed projects reflect sustainable customer demand. This move highlights Beijing's effort to cool investor euphoria over the 'embodied intelligence' theme without undermining a technology deemed a national priority.
Investors are shifting from what one venture capitalist described as 'campaign-style innovation' to a more rational assessment of the sector. Valuations at some robot companies could fall significantly if revenue associated with data-collection centers and joint ventures with local governments is questioned. While the regulatory stance does not signal a retreat from humanoid robotics, it emphasizes a greater focus on deployment, order volumes, and the ability of companies to translate technical demonstrations into commercially viable products.